Posttreatment changes in Escherichia coli antimicrobial susceptibility rates among diarrheic patients treated with ciprofloxacin

Antimicrob Agents Chemother. 2005 Jun;49(6):2571-2. doi: 10.1128/AAC.49.6.2571-2572.2005.

Abstract

Changes in antimicrobial resistance of Escherichia coli among deployed U.S. military personnel being treated for diarrhea were evaluated. Stool samples were collected pretreatment and on days 7, 14, and 28 posttreatment. Resistance to ciprofloxacin was noted in 13.3% of baseline specimens, and rates of resistance against multiple antibiotics increased dramatically from baseline to day 7 and then tapered off to return to pretreatment levels by day 28, except for ciprofloxacin, suggesting that population accumulative usage of fluoroquinolones may result in an incremental increase in resistance rates.

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Ciprofloxacin / pharmacology*
  • Ciprofloxacin / therapeutic use
  • Diarrhea / drug therapy*
  • Diarrhea / microbiology
  • Drug Resistance, Bacterial*
  • Escherichia coli / drug effects*
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / microbiology
  • Feces / microbiology
  • Female
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Military Personnel
  • Treatment Outcome
  • Turkey
  • United States

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin